Table 1.
Nanoparticles | CPPs | Cell lines and/or Effects | Refs |
---|---|---|---|
Liposomes | TATp, Penetratin, Octa-arginine | Calu-3 12- to 17-fold enhanced cell uptake of liposomes |
102 |
TATp | COS-7 | 103 | |
Poly-arginine | NCI-H446, A549, SK-MES-1 Enhanced siRNA intracellular delivery and tumor cell growth inhibition |
104 | |
TAT, Penetratin | SK-BR-3, MCF-7, HTB 9, ADR, A431,C26 12-fold increase of Dox intracellular uptake |
33 | |
TATp | LLC, BT20, H9C2 Enhanced cell uptake of liposomes |
107 | |
CLIO (MION) | TATp | Mouse lymphocytes, human natural killer, HeLa, human hematopoietic CD34+, mouse neural progenitor C17.2, human lymphocytes CD4+, T-cells, B-cells, macrophages, stem cells MRI imaging and magnetic separation of homed cells |
56, 97–99 |
pH sensitive PEG-polylactic acid micelles | TATp | MCF-7 Enhanced cytotoxicity at acidic environment (pH < 7) |
108 |
Gold nanoparticles | TATp Other NLS peptides |
NIH3T3, HepG2, HeLa, hTERT-BJ1 Enhancedcytosolic and nuclear uptake of particles |
109,110 |
Quantum dot-loaded micelles | TATp | MS1, lineage-negative bone marrow cells Dynamic imaging and tracking of labeled cells |
111 |
PEI-PEG-TAT/DNA nanoplexes | TATp | SH-SY5Y Enhanced gene expression |
112 |
TATp | A549 Enhanced gene transfection of lung cells |
113 | |
Boron carbide nanoparticles | TATp | EL4, B16F10 Boron neutron capture therapy |
114 |
Dendrimers | TATp, Penetratin | MDR3T3, MES-SA/Dx5 Enhanced ODN intracellular delivery |
115 |
Solid lipid nanoparticles | DimericTATp | 16HBE14o- Enhanced gene transfection |
116 |